Back to User profile » Dr Mark Suett
Papers published by Dr Mark Suett:
Clinical Benefit and Risk Profile of TV-46000 for Patients with Schizophrenia as Assessed by Number Needed to Treat and Number Needed to Harm
Citrome L, Franzenburg KR, Suett M, Tohami O, Sharon N, Jehassi A, Harary E, Yu D, Correll CU
Neuropsychiatric Disease and Treatment 2026, 22:534730
Published Date: 8 May 2026
Introducing S.C.O.P.E.™ (Schizophrenia Clinical Outcome Scenarios and Patient–Provider Engagement), an Interactive Digital Platform to Educate Healthcare Professionals on Schizophrenia Care
Correll CU, Rubio JM, Citrome L, Mychaskiw MA, Thompson S, Franzenburg KR, Suett M, Kotak S, Kane JM
Neuropsychiatric Disease and Treatment 2024, 20:1995-2010
Published Date: 19 October 2024
TV-46000, A Long-Acting Subcutaneous Antipsychotic Agent, Demonstrated Improved Patient-Centered Outcomes in Patients with Schizophrenia
Citrome L, Suett M, Franzenburg KR, Eshet R, Elgart A, Davis GL 3rd, Harary E, Tohami O, Mychaskiw MA, Kane JM
Neuropsychiatric Disease and Treatment 2024, 20:1901-1917
Published Date: 9 October 2024
Management of Schizophrenia with Long-Acting Injectable Antipsychotic Medications: An Assessment of the Educational Needs of Clinicians
Citrome L, Belcher E, Stacy S, Suett M, Mychaskiw M, Salinas GD
Neuropsychiatric Disease and Treatment 2022, 18:111-123
Published Date: 26 January 2022
Perceived Burdens and Educational Needs of Caregivers of People with Schizophrenia: Results of a National Survey Study
Citrome L, Belcher E, Stacy S, Suett M, Mychaskiw M, Salinas GD
Patient Preference and Adherence 2022, 16:159-168
Published Date: 21 January 2022